MARKET WIRE NEWS

Nkarta GAAP EPS of -$0.29 beats by $0.02

Source: SeekingAlpha

2025-11-10 16:52:13 ET

  • Nkarta press release ( NKTX ): Q3 GAAP EPS of -$0.29 beats by $0.02 .
  • Nkarta had cash, cash equivalents, restricted cash, and investments in marketable securities of $316.5 million as of September 30, 2025.
  • Research and development (R&D) expenses were $20.2 million for the third quarter of 2025. Non-cash stock-based compensation expense included in R&D expense was $0.5 million for the third quarter of 2025.
  • General and administrative (G&A) expenses were $7.1 million for the third quarter of 2025. Non-cash stock-based compensation expense included in G&A expense was $1.2 million for the third quarter of 2025.
  • Net loss was $21.7 million for the third quarter of 2025. This net loss includes non-cash charges of $3.5 million that consisted primarily of share-based compensation, right-of-use asset impairment and depreciation expenses.
  • Nkarta expects its current cash and cash equivalents will be sufficient to fund its current operating plan into 2029.
  • Shares +2.55% AH.

Read the full article on Seeking Alpha

For further details see:

Nkarta GAAP EPS of -$0.29 beats by $0.02
Nkarta Inc.

NASDAQ: NKTX

NKTX Trading

-1.76% G/L:

$2.235 Last:

289,396 Volume:

$2.30 Open:

mwn-app Ad 300

NKTX Latest News

NKTX Stock Data

$142,769,319
65,063,033
0.98%
26
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App